Status:
COMPLETED
The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Coronary Artery Bypass Grafting
Heart Diseases
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this ...
Detailed Description
The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this...
Eligibility Criteria
Inclusion
- Cardiac surgery patients who are between the ages of 18 and 100
- Are English speaking
- Able to give consent
- Undergoing cardiac surgery including (but not limited to):
- Aortic valve replacement (AVR)
- Mitral valve replacement (MVR)
- Tricuspid valve replacement (TVR)
- Coronary artery bypass graft (CABG).
Exclusion
- Non-cardiac surgery patients
Key Trial Info
Start Date :
January 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00226265
Start Date
January 1 1999
End Date
September 1 2007
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States, 10021